A 9-year case report highlights long-term cardiac remodeling in a heterozygote woman with Fabry disease undergoing migalastat therapy. This study provides insights into the chronic effects of treatment on cardiac health in Fabry patients.
long term cardiac remodeling during migalastat therapy in a heterozygote woman with fabry disease n224s a 9 year case report
Original title: “Long-Term Cardiac Remodeling During Migalastat Therapy in a Heterozygote Woman With Fabry Disease (N224S): A 9 Year Case Report.”